- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02224170
Comparison of Effect on Quality of Recovery Outcome Between Systemic Lidocaine and Dexamethasone in Patients Undergoing Laparoscopic Cholecystectomy
March 15, 2019 updated by: Yonsei University
The primary purpose of this study is to compare the effect of lidocaine and dexamethasone on postoperative quality of recovery after laparoscopic cholecystectomy
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
8
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 120-752
- Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ASA I-II patients aged between 20 and 65 year undergoing laparoscopic cholecystectomy due to gallbladder polyp or asymptomatic gallstones without cholecystitis
Exclusion Criteria:
- Steroid therapy or immunocompromised patients
- Diabetes mellitus
- Allergy to lidocaine or dexamethasone
- Severe renal dysfunction (serum creatinine more than 1.6mg/dl)
- Severe liver disease ( liver enzymes more than two times normal values)
- History of atrioventricular block
- Have a difficulty in understanding QoR-40 (40-item quality-of-recovery scoring system) or Korean language
- History of physicologic disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Dexamethasone group
|
Dexamethasone 8mg in normal saline (total volume 25mL) was infused after tracheal intubation, and normal saline was continuously infused at the rate of 0.2 ml Kg-1 h-1 until the end of surgery (at the time of skin closure).
|
Experimental: Lidocaine group
|
Lidocaine 2mg Kg-1 in normal saline (total volume 25mL) was infused after tracheal intubation, and lidocaine was infused at the rate of lidocaine 2mg Kg-1 h-1 (0.2 ml Kg-1 h-1, equivalent volume as normal saline in dexamethasone group) until the end of surgery (at the time of skin closure).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
QoR-40 score
Time Frame: from baseline to 3 hours on the day after surgery
|
40-item quality-of-recovery scoring system
|
from baseline to 3 hours on the day after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence and severity of postoperative nausea and vomiting
Time Frame: from baseline to 3 hours on the day after surgery
|
10 cm-visual analogue scale
|
from baseline to 3 hours on the day after surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to first analgesic request
Time Frame: from baseline to 3 hours on the day after surgery
|
from baseline to 3 hours on the day after surgery
|
|
Number of rescue pain reliever
Time Frame: from baseline to 3 hours on the day after surgery
|
from baseline to 3 hours on the day after surgery
|
|
Severity of postoperative pain
Time Frame: from baseline to 3 hours on the day after surgery
|
10 cm-visual analogue scale
|
from baseline to 3 hours on the day after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Actual)
March 1, 2015
Study Completion (Actual)
March 1, 2015
Study Registration Dates
First Submitted
August 19, 2014
First Submitted That Met QC Criteria
August 21, 2014
First Posted (Estimate)
August 25, 2014
Study Record Updates
Last Update Posted (Actual)
March 19, 2019
Last Update Submitted That Met QC Criteria
March 15, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathological Conditions, Anatomical
- Gallbladder Diseases
- Biliary Tract Diseases
- Calculi
- Cholelithiasis
- Cholecystolithiasis
- Cholecystitis
- Gallstones
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Autonomic Agents
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Antiemetics
- Gastrointestinal Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Dexamethasone
- Lidocaine
Other Study ID Numbers
- 4-2014-0530
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gallbladder Polyp
-
Instituto de Investigación Sanitaria de la Fundación...Not yet recruiting
-
China-Japan Friendship HospitalCompletedA Prospective Randomized Controlled Trial of Lower Abdominal Three-port Laparoscopic CholecystectomyGallbladder Stone | Gallbladder PolypChina
-
Peking Union Medical College HospitalCompleted
-
Yonsei UniversityWithdrawn
-
RenJi HospitalUnknownPolyp of GallbladderChina
-
Peking Union Medical College HospitalUnknownCholecystitis; Gallstone | Cholecystitis/Cholelithiasis | Polyp GallbladderChina
-
Lütfiye Nuri Burat Government HospitalHaseki Training and Research HospitalCompletedPolyp | Gall Stone DiseaseTurkey
-
Lütfiye Nuri Burat Government HospitalCompletedPolyp | Gall Stone DiseaseTurkey
-
University of ManitobaActive, not recruitingPolyps | Colonic Polyp | Polyp of Colon | Colo-rectal Cancer | Colon Polyp | Rectal Polyp | Polyp RectalCanada
-
National Cancer Institute (NCI)CompletedStage II Gallbladder Cancer | Stage IIIA Gallbladder Cancer | Stage IIIB Gallbladder Cancer | Stage IVA Gallbladder Cancer | Stage IVB Gallbladder CancerUnited States
Clinical Trials on Lidocaine
-
Ohio State UniversityCompleted
-
Khon Kaen UniversityNot yet recruitingIntubation | Hemodynamics | Laryngoscopy | Neurosurgery | LidocaineThailand
-
Aswan University HospitalUnknown
-
Benha UniversityCompletedPostcesarean Pain Relief
-
McMaster UniversitySt. Joseph's Healthcare HamiltonWithdrawnIntravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel SurgeryBariatric Surgery Candidate
-
Scilex Pharmaceuticals, Inc.Completed
-
Scilex Pharmaceuticals, Inc.Completed
-
Oregon Health and Science UniversityCompleted
-
Chung-Ang University Hosptial, Chung-Ang University...UnknownPostoperative PainKorea, Republic of
-
Hopital FochCompleted